- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/00 - Drugs for skeletal disorders
Patent holdings for IPC class A61P 19/00
Total number of patents in this class: 2600
10-year publication summary
|
99
|
123
|
126
|
127
|
158
|
174
|
138
|
164
|
111
|
52
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10345 |
34 |
| Takeda Pharmaceutical Company Limited | 2721 |
22 |
| Daiichi Sankyo Company, Limited | 1888 |
20 |
| The Regents of the University of California | 20556 |
19 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3263 |
18 |
| Société des Produits Nestlé S.A. | 9987 |
16 |
| Janssen Pharmaceutica N.V. | 3234 |
16 |
| Osaka University | 3304 |
16 |
| Boehringer Ingelheim International GmbH | 4510 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3334 |
14 |
| Seoul National University R&db Foundation | 4009 |
14 |
| Pfizer Inc. | 3371 |
13 |
| Kyoto University | 2893 |
13 |
| Bristol-myers Squibb Company | 4812 |
12 |
| AstraZeneca AB | 2837 |
12 |
| Warsaw Orthopedic, Inc. | 2816 |
12 |
| The Johns Hopkins University | 5821 |
12 |
| Galapagos NV | 275 |
12 |
| Caregen Co., Ltd. | 319 |
11 |
| Industry Foundation of Chonnam National University | 666 |
11 |
| Other owners | 2288 |